Article Detail - JE Part B
Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58679) - R7 - Effective October 1, 2024
Date Posted: September 12, 2024
This Local Coverage Article (LCA) has been revised under contractor numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).
Effective Date: October 1, 2024
Summary of Changes:
Under ICD-10 Codes that Support Medical Necessity Group 1: Codes deleted Z86.010. Added Z86.0101. This revision is due to the Annual ICD-10-CM Code Update and will become effective on 10/1/2024.
Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCDs or access it via the CMS MCD.